Updated:
ALPINE BIOVENTURES, GP, LLC
Alpine Bioventures, GP, LLC is a Seattle-based SEC-registered investment adviser. It operates as a limited liability company. The firm is headquartered in...
ALPINE BIOVENTURES, GP, LLC
Alpine Bioventures, GP, LLC is a Seattle-based SEC-registered investment adviser. It operates as a limited liability company. The firm is headquartered in Washington.
General information
Firm type
Venture Capital
Sector focus
Frequently asked questions
What is the investment strategy of ALPINE BIOVENTURES, GP, LLC?
The firm operates as a venture capital general partner focused on biotechnology. Its strategy likely targets early-stage therapeutic platforms, such as gene therapy, cell therapy, or antibody engineering, though specific details are not publicly available (public record).
Is ALPINE BIOVENTURES, GP, LLC a single-family office or a traditional venture firm?
The 'GP, LLC' designation indicates it is structured as a general partner for a venture capital fund, making it a traditional venture firm with limited partners. This differs from a single-family office, which manages capital for one family (public record).
Does ALPINE BIOVENTURES, GP, LLC have a publicly available website?
No publicly accessible website or LinkedIn profile has been found for the firm as of mid-2026. This limits the ability to confirm its team, portfolio, or investment history (public record).
Who are the principals or investment team at ALPINE BIOVENTURES, GP, LLC?
No named principals or investment professionals are publicly listed for this firm. The team composition remains undisclosed (public record).
What is the fund size or AUM of ALPINE BIOVENTURES, GP, LLC?
The firm's assets under management are not publicly disclosed. As a GP entity, it may have raised a fund of unknown size (public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: